Latest News

19 Aug 2013 The Future Development of Targeted Therapies in the Era of Genomics Personalised medicine
19 Aug 2013 Signatures of Mutational Processes in Cancer Translational research
31 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Filgrastim (Grastofil) Palliative and supportive care - Anticancer agents & Biologic therapy
30 Jul 2013 European Medicines Agency Recommends Changes to the Use of Metoclopramide Palliative and supportive care - Anticancer agents & Biologic therapy
29 Jul 2013 European Medicines Agency recommends granting a marketing authorisation for afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Jul 2013 A New Paradigm Shift: Platinum-Based Doublets Better than Monotherapy even in Patients with Advanced Non-Small Cell Lung Cancer and Performance Status 2 Lung and other thoracic tumours
24 Jul 2013 WINTHER Trial Aims to Offer Improved Cancer Care Personalised medicine - Anticancer agents & Biologic therapy
Clinical Research Fellowship in Oncology Targeted Therapy in Melanoma, UK
23 Jul 2013 Paradoxical Oncogenic Transformation Melanoma - Anticancer agents & Biologic therapy
22 Jul 2013 Radium-223 in Metastatic Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
19 Jul 2013 Aflibercept in Colorectal Cancer: Indication of Minor Added Benefit Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jul 2013 FDA Approves Afatinib for the First Line Treatment of Patients with Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Jul 2013 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy